Tina Rashid
She/her
Tina Rashid completed her specialist urology training on the North-West Thames Rotation, gaining experience across major London teaching hospitals including Charing Cross and University College London Hospitals. In 2012, she was awarded the Keith Yates Gold Medal for the highest national score in the postgraduate urology examinations.
She undertook competitive fellowships in female and reconstructive urology, first at University Hospitals of Leicester and later at Leuven University Hospital in Belgium—an internationally recognised centre of excellence.
In 2014, Tina was appointed Consultant at Imperial College Healthcare NHS Trust, where she helped to develop the female and functional urology unit and the Genital Reconstructive Surgery (GRS) Teams. She remained at Imperial until 2021, before joining St George’s University Hospitals NHS Foundation Trust (2022–2024), where she delivered its gender surgery programme. In 2024, she joined Chelsea and Westminster Hospital to mentor and work alongside the existing team. Alongside her role at Parkside Hospital (since 2016), Tina has maintained a continuous commitment to NHS-commissioned gender surgery. At a time of significant strain, she has remained embedded within them, helping sustain capacity and improve pathways for patients.
She has performed over 1,500 primary lower feminising surgeries. Recent additions to her practice include peritoneal vaginoplasty and involvement in phalloplasty, broadening the scope of care she offers.
In 2022, she was appointed NHS England’s National Clinical Lead for Gender Dysphoria Surgery, a role in which she contributes to shaping national policy, drives service expansion, and within which she established and directs the first London Gender Surgery Fellowship Programme.
Alongside her clinical leadership, Tina has published over 40 peer-reviewed papers, 11 book chapters, and delivered more than 40 national and international presentations. Passionate about equity and inclusion, she continues to advocate for an underserved population and drive evidence-based improvements in access, safety, and outcomes.